Catecholaminergic Modulation of Metacontrol Is Reflected by Changes in Aperiodic EEG Activity
International Journal of Neuropsychopharmacology · 01.08.2024 · 27 (8)
DOI: 10.1093/ijnp/pyae033 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 03.08.2024. Verfasst von Yang Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, Shandong Normal University, Jinan, China. Hauptthemen laut MEDLINE: Methylphenidate, Electroencephalography. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background “Metacontrol” describes the ability to maintain an optimal balance between cognitive control styles that are either more persistent or more flexible. Recent studies have shown a link between metacontrol and aperiodic EEG patterns. The present study aimed to gain more insight into the neurobiological underpinnings of metacontrol by using methylphenidate (MPH), a compound known to increase postsynaptic catecholamine levels and modulate cortical noise.
Methods
In a double-blind, randomized, placebo-controlled study design, we investigated the effect of MPH (0.5 mg/kg) on aperiodic EEG activity during a flanker task in a sample of n = 25 neurotypical adults. To quantify cortical noise, we employed the fitting oscillations and one over f algorithm.
Results
Compared with placebo, MPH increased the aperiodic exponent, suggesting that it reduces cortical noise in 2 ways. First, it did so in a state-like fashion, as the main effect of the drug was visible and significant in both pre-trial and within-trial periods. Second, the electrode-specific analyses showed that the drug also affects specific processes by dampening the downregulation of noise in conditions requiring more control.
Conclusions
Our findings suggest that the aperiodic exponent provides a neural marker of metacontrol states and changes therein. Further, we propose that the effectiveness of medications targeting catecholaminergic signaling can be evaluated by studying changes of cortical noise, fostering the idea of using the quantification of cortical noise as an indicator in pharmacological treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Psychology, Shandong Normal University, Jinan, China.
- Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.
ORCID-Profile: Bernhard Hommel
Zitieren
APA
Gao, Y., Roessner, V., Stock, A. K., Mückschel, M., Colzato, L., Hommel, B., & Beste, C. (2024). Catecholaminergic Modulation of Metacontrol Is Reflected by Changes in Aperiodic EEG Activity. International Journal of Neuropsychopharmacology, 27(8). https://doi.org/10.1093/ijnp/pyae033
Vancouver
Gao Y, Roessner V, Stock AK, Mückschel M, Colzato L, Hommel B, et al. Catecholaminergic Modulation of Metacontrol Is Reflected by Changes in Aperiodic EEG Activity. International Journal of Neuropsychopharmacology. 2024;27(8). doi:10.1093/ijnp/pyae033
BibTeX
@article{Gao2024,
author = {Gao, Yang and Roessner, Veit and Stock, Ann-Kathrin and Mückschel, Moritz and Colzato, Lorenza and Hommel, Bernhard and Beste, Christian},
title = {Catecholaminergic Modulation of Metacontrol Is Reflected by Changes in Aperiodic EEG Activity},
journal = {International Journal of Neuropsychopharmacology},
year = {2024},
volume = {27},
number = {8},
doi = {10.1093/ijnp/pyae033}
}
EUVIMED